Similarly, treatments with CML (400 μM) and PENT (2 μM) reduced myotube area (Figure S1A,B) and MyHC expression to a similar extent as MGO (Figure S1C). Here, MYH6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.